Novel gene silencing therapy for cervical cancer
18th Nov 2005, 18:29 GMT
Sydney, A team of researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR) has pioneered a new gene silencing therapy for the treatment of cervical cancer, which is the leading cause of cancer death in women aged 25-50 worldwide.
Novel gene silencing therapy for cervical cancer related news:
- Novel gene silencing therapy for cervical cancer — Health News
- New approach for the treatment of cervical cancer - New gene silencing therapy — Medical News Today RSS/XML Feed
- New Gene Silencing Therapy For Cervical Cancer — ScienceDaily Headlines
- Women Still at Cervical Cancer Risk After CIN Therapy — MedPage Today Hematology/Oncology
- Hypoxia- and radiation-activated Cre/loxP ‘molecular switch’ vectors for gene therapy of cancer — Gene Therapy
- Scottish women, who have high incidence of cervical cancer, given vaccine — The Cancer Blog
- Cervical cancer shots win some conservative favor (Reuters) —
- Scots teenagers first to test cervical cancer vaccine — Scotsman.com News
- Cervical cancer cells warning — Scotsman.com News - UK
- Radiation Therapy Increases Hip and Other Pelvic Fracture Risk — MedPage Today Hematology/Oncology
Latest news from KeralaNext: Health:
- In Heart Patients Smoking related to Cognitive Decline
- Tool Helps to Predicts Post-Surgery Breast Cancer Recurrence
- Breath Test help to predict Lung Cancer; Scientists
- Study Emphasizes Older Women's Risk for bone fractures
- Scientists discovered Anti-Cancer Compound in Green Tea
- Tea could block the spread of HIV
- Stem cells give hope for diabetes cure
- Study says, Late-life pregnancies risky, but birth outcomes are good
- Over 300,000 drug Lankans hooked
- Study says, Red meat connected to some breast cancers